Rxivist logo

Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay

By James P. Broughton, Xianding Deng, Guixia Yu, Clare L. Fasching, Jasmeet Singh, Jessica Streithorst, Andrea Granados, Alicia Sotomayor-Gonzalez, Kelsey C Zorn, Allan Gopez, Elaine Hsu, Wei Gu, Steve Miller, Chao-Yang Pan, Hugo Guevara, Debra A Wadford, Janice S Chen, Charles Y Chiu

Posted 10 Mar 2020
medRxiv DOI: 10.1101/2020.03.06.20032334

An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the development of SARS-CoV-2 DETECTR, a rapid ([~]30 min), low-cost, and accurate CRISPR-Cas12 based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated this method using contrived reference samples and clinical samples from infected US patients and demonstrated comparable performance to the US CDC SARS-CoV-2 real-time RT-PCR assay.

Download data

  • Downloaded 24,413 times
  • Download rankings, all-time:
    • Site-wide: 399
    • In infectious diseases: 153
  • Year to date:
    • Site-wide: 5,930
  • Since beginning of last month:
    • Site-wide: 3,615

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide